Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Maire

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Plos One|September 17, 2013
Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier stateAllan Saul, Tom Smith, Nicolas Maire
Drugs - Real World Outcomes|October 18, 2016
Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and PeruCyril Nogier, Patrick Hanlon, Karin Wiedenmayer, et al.
The American Journal of Tropical Medicine and Hygiene|August 26, 2006
An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparumAmanda Ross, Nicolas Maire, Louis Molineaux, et al.
The American Journal of Tropical Medicine and Hygiene|August 26, 2006
Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan AfricaNicolas Maire, Fabrizio Tediosi, Amanda Ross, et al.
Plos One|September 1, 2017
Assessing the population coverage of a health demographic surveillance system using satellite imagery and crowd-sourcingAurelio Di Pasquale, Robert S McCann, Nicolas Maire
Plos One|April 15, 2011
Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenAmanda Ross, Nicolas Maire, Elisa Sicuri, et al.
Malaria Journal|June 10, 2009
Simulation of the cost-effectiveness of malaria vaccinesFabrizio Tediosi, Nicolas Maire, Melissa Penny, et al.
Epidemics|February 14, 2012
Can we depend on case management to prevent re-establishment of P. falciparum malaria, after local interruption of transmission?Valerie Crowell, Diggory Hardy, Olivier Briët, et al.
Malaria Journal|August 5, 2015
Asymptomatic Plasmodium falciparum infections may not be shortened by acquired immunityMichael T Bretscher, Nicolas Maire, Ingrid Felger, et al.
Plos One|September 12, 2008
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccinesMelissa A Penny, Nicolas Maire, Alain Studer, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Plos One|September 17, 2013
Stochastic simulation of endemic Salmonella enterica serovar Typhi: the importance of long lasting immunity and the carrier stateAllan Saul, Tom Smith, Nicolas Maire
Drugs - Real World Outcomes|October 18, 2016
Can a Compact Pre-Filled Auto-Disable Injection System (cPAD) Save Costs for DTP-HepB-Hib Vaccine as Compared with Single-Dose (SDV) and Multi-Dose Vials (MDV)? Evidence from Cambodia, Ghana, and PeruCyril Nogier, Patrick Hanlon, Karin Wiedenmayer, et al.
The American Journal of Tropical Medicine and Hygiene|August 26, 2006
An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparumAmanda Ross, Nicolas Maire, Louis Molineaux, et al.
The American Journal of Tropical Medicine and Hygiene|August 26, 2006
Predictions of the epidemiologic impact of introducing a pre-erythrocytic vaccine into the expanded program on immunization in sub-Saharan AfricaNicolas Maire, Fabrizio Tediosi, Amanda Ross, et al.
Plos One|September 1, 2017
Assessing the population coverage of a health demographic surveillance system using satellite imagery and crowd-sourcingAurelio Di Pasquale, Robert S McCann, Nicolas Maire
Plos One|April 15, 2011
Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and childrenAmanda Ross, Nicolas Maire, Elisa Sicuri, et al.
Malaria Journal|June 10, 2009
Simulation of the cost-effectiveness of malaria vaccinesFabrizio Tediosi, Nicolas Maire, Melissa Penny, et al.
Epidemics|February 14, 2012
Can we depend on case management to prevent re-establishment of P. falciparum malaria, after local interruption of transmission?Valerie Crowell, Diggory Hardy, Olivier Briët, et al.
Malaria Journal|August 5, 2015
Asymptomatic Plasmodium falciparum infections may not be shortened by acquired immunityMichael T Bretscher, Nicolas Maire, Ingrid Felger, et al.
Plos One|September 12, 2008
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccinesMelissa A Penny, Nicolas Maire, Alain Studer, et al.
Pageof 5